Peter Werder has been appointed CEO of Spital Linth

Peter Werder (45) will take on his new position on 1 February 2020 and will replace Dr. Urs Graf , who will retire on this date. Dr. Werder joined the Hirslanden Private Hospital Group in 2011 as Head of Corporate Communication. From 2016 to 2019, he was Hospital Manager at Hirslanden Klinik Belair in Schaffhausen. 

He did his Executive MBA in General Management at the University of St. Gallen from 2013 to 2014 and graduated with the master thesis “Centralisation and standardisation at hospitals”. 

During his time as Hospital Manager of Klinik Belair, Peter Werder realised many infrastructure projects and expanded the hospital's market area. He put the hospital’s shift to outpatient care into practice and implemented Group projects to bring Klinik Belair up to date in the areas of procurement, logistics, digitisation and standardisation. 

The Executive Committee of the Hirslanden Private Hospital Group would like to warmly thank Peter Werder for this contribution and wishes him all the best and every success for the future and the coming challenges. 

He will work on the establishment of innovation management at the Hirslanden Private Hospital Group until he takes up his new position.

About Hirslanden

The Hirslanden Private Hospital Group consists of 17 hospitals in 10 cantons, many of which have an outpatient surgery unit and an emergency department. The Group also operates 3 outpatient clinics, 2 outpatient surgery units, 17 radiology institutes and 5 radiotherapy institutes. As at 31 March 2019, the Group had 2,303 affiliated doctors and 10,442 employees, of whom 510 are permanently employed doctors. 

Hirslanden is the leading private hospital group and the largest medical network in Switzerland. In the 2018/19 financial year, the Group generated turnover of CHF 1,778 million. As at 31 March 2019, the Group had treated 106,851 patients, amounting to a total of 479,631 inpatient days. In insurance terms, the patient mix consists of 48.7% basic, 29.5% semi-private, and 21.8% private insured patients. 

The Hirslanden Private Hospital Group is synonymous with first-class medical care provided by highly qualified medical specialists with years of experience. As a system provider, Hirslanden stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes enable it to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Private Hospital Group was formed in 1990 through the merger of several Swiss private hospitals. Since 2007 it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.